Stirling Newberry, Firedoglake AlterNet: Corporate Accountability and WorkPlace. October 10, 2008. For those of you who slept well last night, here is what happened.
Jason Linkins, Huffington Post AlterNet: PEEK. September 22, 2008. "Decisions by the Secretary ... are non-reviewable ... and may not be reviewed by any court of law or any administrative agency."
Bruce E. Levine, AlterNet. August 15, 2008. Depression is rooted in overwhelming emotional pain. Talk therapy is a successful, commonsense antidote, but pushing pills pays more.
Max Keiser, Huffington Post AlterNet: PEEK. July 21, 2008. The dollar is crashing and the economy tanking; yet some American's are rallying to "save their Starbucks." Talk about denial.
Martha Rosenberg, AlterNet. April 28, 2008. Drug company spin does not change the fact that Cymbalta has been linked to suicide -- even in otherwise mentally healthy people.
John Miller, Dollars and Sense. February 8, 2008. The economic recovery underway since late 2001 is probably over. Too bad many Americans never got to experience it.
Bob Fertik, Democrats.com. January 25, 2008. Why is it that, since Reagan came to Washington in 1981, "bipartisan unity" has always meant Democratic capitulation to Republicans?
Barbara Ehrenreich, Barbaraehrenreich.com. January 10, 2008. Growth and productivity mean nothing when they are de-coupled from most people's lived experience: being squeezed.
Bruce E. Levine, AlterNet. January 9, 2008. Many prescription drugs have effects similar to those of illegal drugs. But we still view some users as criminals -- the others as patients.
Kathy Kastan, Huffington Post. December 19, 2007. Suicide rates are alarmingly high among middle-aged Americans, and the holiday season often amplifies the problem.
Bruce E. Levine, Chelsea Green Publishing. November 26, 2007. It would be a lot easier to address the increasing rate of depression among Americans if we weren't so afraid to admit that our consumer society makes us unhappy.
Bruce E. Levine, Z Magazine. November 14, 2007. The author of a new book on depression shows how Big Pharma is cashing in on drugs that aren't likely to help mood disorders.
